Abstract
From 1970 to 1982, 157 consecutive patients with de novo acute nonlymphocytic leukemia (ANLL) were treated and followed by the Hematology Unit at the Brigham and Women’s Hospital, Boston, Massachusetts. It was in 1970, with the addition of cytosine arabinoside and daunorubicin, that remission induction (RI) rates significantly increased from 30% to greater than 50% [1]. During the past decade, major emphasis has been placed on an attempt to prolong disease-free survival with intensive chemotherapy programs and more recently with allogeneic and syngeneic bone marrow transplantation [2, 3]. Since 1970, we have attempted to treat our patients with more aggressive remission and maintenance consolidation (RC) programs.
Division of Hematology, Department of Medicine, Brigham and Women’s Hospital and Harvard Medical School, Boston, Mass, USA
This is a preview of subscription content, log in via an institution to check access.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
References
Gale RPL (1979) Advances in the treatment of acute myelogenous leukemia. N Engl J Med 300: 1189–1199
Weinstein HJ, Mayer RT, Rosenthal DS, Camitta BM, Coral FS, Nathan DG, Frei E III (1980) Treatment of acute myelogenous leukemia in children and adults. N Engl J Med 303: 473–478
Thomas ED, Buckner CD, Clift RA et al. (1979) Marrow transplantation for acute nonlymphoblastic leukemia in first remission. N Engl J Med 301: 597–599
Rosenthal DS, Moloney WC (1972) The treatment of acute granulocytic leukemia in adults. N Engl J Med 286: 1176–1178
Sauter C, Fopp M, Imbach P, Tschopp L, Berchtold LW, Gratwohl A, Maurice P, Von-Fliedner V, Cavalli F (1984) Acute myelogenous leukemia: Maintenance chemotherapy after early consolidation treatment does not prolong survival. Lancet 1: 379–382
Marcus RE, Catovsky D, Goldman JM, Worsley AM, Galton DAG (1984) Maintenance and consolidation therapy in AML. Lancet 1: 686–687
Emerson S, Rosenthal DS, Moloney WC, Handin RI (1983) Limited impact of intensive combination chemotherapy in adult acute myelogenous leukemia. Blood 62:201 a
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 1985 Springer-Verlag Berlin Heidelberg
About this paper
Cite this paper
Rosenthal, D.S., Emerson, S.E., Rappeport, J.M., Moloney, W.C., Handin, R.I. (1985). Long-Term Survivors of Adult Acute Nonlymphocytic Leukemia: Fact or Fiction?. In: Neth, R., Gallo, R.C., Greaves, M.F., Janka, G. (eds) Modern Trends in Human Leukemia VI New Results in Clinical and Biological Research Including Pediatric Oncology. Haematology and Blood Transfusion / Hämatologie und Bluttransfusion, vol 29. Springer, Berlin, Heidelberg. https://doi.org/10.1007/978-3-642-70385-0_9
Download citation
DOI: https://doi.org/10.1007/978-3-642-70385-0_9
Publisher Name: Springer, Berlin, Heidelberg
Print ISBN: 978-3-540-15329-0
Online ISBN: 978-3-642-70385-0
eBook Packages: Springer Book Archive